tiprankstipranks
Trending News
More News >

Helen Kuhlman Insider Profile

4 Followers
Helen Kuhlman, Chief Business Officer at Evgen Pharma, holds 2.56M shares in Evgen Pharma (Ticker: GB:TCF). Most recently, Helen Kuhlman Bought 1,500,000p shares of Evgen Pharma on Mar 04, 2025 for an estimated value of 3.60K.
tipranks
Helen  Kuhlman

Helen Kuhlman
Evgen Pharma (TCF)
Chief Business Officer

Ranked #77,195 out of 100,956 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

-35.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

£6K
100.00%
A breakdown of Helen Kuhlman's holdings

Insider Roles

Evgen Pharma
(TCF)
Chief Business Officer
Roles that Helen Kuhlman holds in companies

Most Profitable Insider Trade

Stock:
Evgen Pharma
(TCF)
Rating:Informative Buy
Date:Mar 04, 2025 - Today
Return:+4.40%
The most profitable trade made by Helen Kuhlman

Helen Kuhlman's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Evgen Pharma
Mar 04, 2025
Chief Business Officer
Informative Buy
3.60K
£6.01K
Success Rate for
TCF
1 out of 2 profitable transactions on
TCF
50%
Average Return for
TCF
Average return per transaction on
TCF
-35.70%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Mar 20, 2024
Informative Buy
£10.00K
-
£1.00
-75.80%
Mar 04, 2025
Informative Buy
£3.60K
-
£0.00
+4.40%
List of latest transactions for each holding click on a transaction to see Helen Kuhlman's performance on stock

Helen Kuhlman insider profile FAQ

What is the percentage of profitable transactions made by Helen Kuhlman?
The percentage of profitable transactions made by Helen Kuhlman is 50%.
    What is the average return per transaction made by Helen Kuhlman?
    The average return per transaction made by Helen Kuhlman is -35.70%.
      What stocks does Helen Kuhlman hold?
      Helen Kuhlman holds: GB:TCF stocks.
        What was Helen Kuhlman’s latest transaction?
        Helen Kuhlman latest transaction was an Informative Buy of 3.60K.
          What was Helen Kuhlman's most profitable transaction?
          Helen Kuhlman’s most profitable transaction was an Informative Buy of GB:TCF stock on March 4, 2025. The return on the trade was 4.40%.
            What is Helen Kuhlman's role in Evgen Pharma?
            Helen Kuhlman's role in Evgen Pharma is Chief Business Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.